Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BBIO
#662
BridgeBio Pharma, Inc. - Common Stock
83.0
8
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.27%
Monthly Change
+24.11%
6 month change
+10.76%
Year Change
+45.75%
Previous Close
85.8
9
Open
83.0
8
Low
83.0
8
High
83.0
8
Volume
129
Markets
US Stock Market
Healthcare
Biotechnology
BBIO
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
148.96 M
147.61 M
151.37 M
175.83 M
190.19 M
193.86 M
195.86 M
Valuation ratios
Enterprise value
10.38 B
2.5 B
1.15 B
7.19 B
4.99 B
14.27 B
16.12 B
Price to earnings ratio
—
—
-2.2
-10.24
-9.53
-20.24
-23.2
Price to sales ratio
—
—
13.62
707.83
23.01
29.18
—
Price to cash flow ratio
—
—
-2.52
-12.48
-9.81
-32.85
-37.69
Price to book ratio
—
—
-0.84
-4.86
-3.48
-7.02
-2.06
Enterprise value to EBITDA ratio
—
-4.38
-2.28
-11.97
-8.49
-27.55
—
Profitability ratios
Return on assets %
-0.72
-0.58
-0.78
-1.2
-0.59
-0.78
-0.12
Return on equity %
-4.76
0.68
0.39
0.49
0.37
0.35
0.07
Return on invested capital %
-1 947.71
-1 696.81
-1 371.23
-2 019.58
-1 289.91
-776.22
—
Gross margin %
100
96.08
100
73.71
98.25
95.82
94.89
Operating margin %
-5 751.99
-827.12
-659.65
-6 528.75
-267.22
-104.25
-54.47
EBITDA margin %
—
-818.73
-650.93
-6 458.95
-264.49
-103.17
-53.86
Net margin %
-6 127.87
-841.2
-624.17
-7 021.94
-244.86
-145.98
-85.63
Liquidity ratios
Quick ratio
—
—
—
—
—
2.68
1.48
Current ratio
6.72
6.58
4.52
3.32
4.67
2.77
1.52
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.08
0.09
0.02
0.3
0.54
0.17
Solvency ratios
Debt to assets ratio
0.13
0.43
0.69
0.82
0.48
—
—
Debt to equity ratio
1.6
-0.49
-0.34
-0.33
-0.3
—
—
Long term debt to total assets ratio
—
0.09
—
—
—
2.14
1.94
Long term debt to total equity ratio
—
-0.11
—
—
—
-0.96
-1.16
Per share metrics
Operating cash flow per share
—
—
-2.84
-3.24
-2.8
-2.33
-2.3
EBIT per share
—
—
-3.47
-3.73
-3.19
-2.73
-2.73
EBITDA per share
—
—
-3.43
-3.69
-3.15
-2.7
-2.71
Total debt per share
—
—
2.92
2.74
2.35
—
—
Cash per share
—
—
3.2
2.67
3.66
3.07
4.83
Net current asset value per share
—
—
3.72
2.93
3.87
4.17
6.37
Tangible book value per share
—
—
-8.51
-8.32
-7.89
-10.89
-11.7
Working capital per share
—
—
2.9
2.05
3.04
2.66
2.18
Book value per share
—
—
-8.51
-8.32
-7.89
-10.89
-11.7
News
BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play (NASDAQ:BBIO)
Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists
How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High
Stock Market Mixed As Oil Prices Jump; Delta Air, SK Hynix In Focus: Weekly Review
BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last?
Broadcom Inks Pact With Meta, Leads 21 Top Performers Onto Best Stock Watchlists
Alnylam: Unexpected Rival Trial Failure Improves Core TTR Franchise Outlook (ALNY)
AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study
Why AstraZeneca Crashed 8%, Leading Three Rivals, Including Pfizer, To Jump
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts